These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2557156)
1. Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts. Tosaki A; Koltai M; Braquet P; Szekeres L Cardiovasc Res; 1989 Aug; 23(8):715-22. PubMed ID: 2557156 [TBL] [Abstract][Full Text] [Related]
2. Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts. Koltai M; Tosaki A; Hosford D; Esanu A; Braquet P Cardiovasc Res; 1991 May; 25(5):391-7. PubMed ID: 1855244 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. Piper PJ; Stewart AG Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369 [TBL] [Abstract][Full Text] [Related]
4. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. Koltai M; Lepran I; Szekeres L; Viossat I; Chabrier E; Braquet P Eur J Pharmacol; 1986 Oct; 130(1-2):133-6. PubMed ID: 3780855 [TBL] [Abstract][Full Text] [Related]
5. Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion. Koltai M; Tosaki A; Hosford D; Braquet P Eur J Pharmacol; 1989 May; 164(2):293-302. PubMed ID: 2759177 [TBL] [Abstract][Full Text] [Related]
6. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723 [TBL] [Abstract][Full Text] [Related]
7. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. Cirino M; Lagente V; Lefort J; Vargaftig BB Prostaglandins; 1986 Jul; 32(1):121-6. PubMed ID: 3763941 [TBL] [Abstract][Full Text] [Related]
8. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis. Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923 [TBL] [Abstract][Full Text] [Related]
9. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart. Viossat I; Chapelat M; Chabrier PE; Braquet P Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):189-94. PubMed ID: 2622972 [TBL] [Abstract][Full Text] [Related]
10. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. Desquand S; Lefort J; Dumarey C; Vargaftig BB Br J Pharmacol; 1991 Mar; 102(3):687-95. PubMed ID: 1285397 [TBL] [Abstract][Full Text] [Related]
12. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. Touvay C; Vilain B; Taylor JE; Etienne A; Braquet P Prog Lipid Res; 1986; 25(1-4):277-88. PubMed ID: 2827186 [No Abstract] [Full Text] [Related]
13. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. Touvay C; Etienne A; Braquet P Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists. Darius H; Smith JB; Lefer AM Int Arch Allergy Appl Immunol; 1986; 80(4):369-75. PubMed ID: 3015804 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Vilain B; Lagente V; Touvay C; Desquand S; Randon J; Lefort J; Braquet P; Vargaftig BB Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840 [TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists. Mathison R; Davison JS; Befus AD Br J Pharmacol; 1992 Jun; 106(2):263-6. PubMed ID: 1393261 [TBL] [Abstract][Full Text] [Related]
17. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N; Etienne A; Braquet P Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108 [TBL] [Abstract][Full Text] [Related]
18. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts. Vleeming W; Wemer J; Porsius AJ J Cardiovasc Pharmacol; 1992; 20(5):790-9. PubMed ID: 1280743 [TBL] [Abstract][Full Text] [Related]
19. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs. Heuer HO Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736 [TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig. Touvay C; Vilain B; Lejeune V; Mencia-Huerta JM; Braquet P Biochem Biophys Res Commun; 1989 Aug; 163(1):118-23. PubMed ID: 2775253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]